Earnings summaries and quarterly performance for Ingevity.
Research analysts who have asked questions during Ingevity earnings calls.
DR
Daniel Rizzo
Jefferies
6 questions for NGVT
Also covers: APD, ASH, ATR +16 more
John McNulty
BMO Capital Markets
6 questions for NGVT
Also covers: APD, ASH, AVY +15 more
Michael Sison
Wells Fargo
4 questions for NGVT
Also covers: ALB, APD, ASH +16 more
JT
Jonathan Tanwanteng
CJS Securities
3 questions for NGVT
Also covers: APG, ATRO, CMCO +17 more
LJ
Lee Jagoda
CJS Securities
3 questions for NGVT
Also covers: GFF, HLMN, MODV +3 more
Abigail Eberts
Wells Fargo
2 questions for NGVT
Also covers: ALB, IFF, LIN +1 more
Recent press releases and 8-K filings for NGVT.
Ingevity Announces Q4 and Full Year 2025 Results and 2026 Outlook
NGVT
Earnings
Guidance Update
M&A
- Ingevity completed the sale of its North Charleston crude tall oil refinery assets and the majority of the Performance Chemicals Industrial Specialties product line on January 1, 2026. The company also announced the exploration of strategic alternatives for its Advanced Polymer Technologies segment and Road Markings product line in December.
- For the full year 2025, Ingevity reported total net sales of $1,289.2 million, an 8% decline year-over-year, and total adjusted EBITDA of $397.5 million. The company generated $274 million of free cash flow, the highest in five years, and improved its net leverage to 2.6 times from 3.5 times at the end of 2024.
- Ingevity provided a full year 2026 outlook, projecting net sales between $1.1 billion and $1.2 billion, adjusted EBITDA between $380 million and $400 million, and free cash flow between $225 million and $250 million. The company also expects to buy back $300 million worth of shares through the end of 2027.
1 day ago
Ingevity Reports Q4 and Full-Year 2025 Results, Provides 2026 Guidance
NGVT
Earnings
Guidance Update
M&A
Share Buyback
- Ingevity reported strong full-year 2025 results, with Adjusted EBITDA increasing 10% to $398 million and Adjusted EPS improving 30% to $4.55, driven by $274 million in free cash flow and a reduction in net leverage to 2.6x.
- The company completed the sale of its Industrial Specialties product line on January 1, 2026, and is actively pursuing sales processes for its Advanced Polymer Technologies segment and Road Markings product line.
- For 2026, Ingevity provided guidance including Adjusted EPS between $4.08 and $5.20, sales between $1.1 billion and $1.2 billion, and Adjusted EBITDA between $380 million and $400 million.
- The company plans to generate $225 million-$250 million in free cash flow in 2026, which will be used to continue share repurchases, targeting $300 million through 2027, and to maintain net leverage within 2x-2.5x.
1 day ago
Ingevity Reports Strong FY 2025 Results and Provides 2026 Guidance
NGVT
Earnings
Guidance Update
M&A
- Ingevity reported strong full-year 2025 results, with total company adjusted EBITDA increasing by almost 10% to $398 million and diluted adjusted EPS improving 30% to $4.55. The company generated $274 million in free cash flow and reduced net leverage to 2.6x.
- The sale of the North Charleston CTO refinery and the majority of the Industrial Specialties product line was completed on January 1, 2026. Ingevity also initiated sales processes for its Advanced Polymer Technologies (APT) segment and Road Markings product line.
- For 2026, Ingevity expects adjusted EPS to be between $4.08 and $5.20, sales between $1.1 billion and $1.2 billion, and adjusted EBITDA between $380 million and $400 million.
- The company plans to generate $225 million-$250 million in free cash flow in 2026 and continue share repurchases, targeting $300 million through 2027. It also aims to reduce and maintain net leverage within 2x-2.5x in 2026.
- Phil Platt has been named the incoming CFO, succeeding Mary Dean Hall.
1 day ago
Ingevity Reports Strong 2025 Financials and Outlines 2026 Outlook Amid Portfolio Optimization
NGVT
Earnings
Guidance Update
M&A
- Ingevity reported strong full-year 2025 results, with total company adjusted EBITDA increasing almost 10% year-over-year to $398 million and diluted adjusted EPS improving 30% to $4.55. The company generated $274 million in free cash flow and reduced net leverage to 2.6x.
- The company completed the sale of its Industrial Specialties product line on January 1, 2026, and is progressing with sales processes for its Advanced Polymer Technologies (APT) and Road Markings product lines.
- For 2026, Ingevity expects adjusted EPS to be between $4.08-$5.20, sales between $1.1 billion-$1.2 billion, and adjusted EBITDA between $380 million-$400 million.
- Ingevity plans to generate $225 million-$250 million in free cash flow in 2026 and intends to complete $300 million in share repurchases through 2027, aiming to maintain net leverage within a 2x-2.5x target range.
1 day ago
Ingevity Reports Full Year and Fourth Quarter 2025 Financial Results and Provides 2026 Outlook
NGVT
Earnings
Guidance Update
M&A
- Ingevity reported a net loss of $167.1 million and diluted loss per share of $4.61 for full year 2025, primarily due to $293.1 million in non-cash pre-tax special charges. Net sales from continuing operations were $1.2 billion, down 3% from the prior year, while diluted adjusted EPS from continuing operations increased to $4.13.
- The company generated $273.5 million in free cash flow for full year 2025 and improved its net leverage to 2.6 times.
- Strategic actions included the completion of the sale of its North Charleston crude tall oil refinery assets and the majority of its Performance Chemicals Industrial Specialties product line, alongside initiating the exploration of strategic alternatives for its Advanced Polymer Technologies segment and Performance Chemicals Road Markings product line.
- For full year 2026, Ingevity anticipates net sales between $1.1 billion and $1.2 billion, adjusted EBITDA between $380 million and $400 million, and adjusted EPS between $4.80 to $5.20.
2 days ago
Ingevity Reports Full Year and Fourth Quarter 2025 Financial Results
NGVT
Earnings
Guidance Update
M&A
- Ingevity reported full year 2025 total net sales of $1.3 billion, an 8% decrease from the prior year, with a net loss of $167.1 million and diluted loss per share of $4.61. Adjusted EBITDA from continuing operations was $373.0 million, and diluted adjusted EPS from continuing operations was $4.13.
- The company completed the sale of its North Charleston crude tall oil refinery assets and the majority of its Performance Chemicals Industrial Specialties product line, and initiated the exploration of strategic alternatives for its Advanced Polymer Technologies segment and Performance Chemicals Road Markings product line.
- For the full year 2025, Ingevity generated operating cash flow of $331.2 million and free cash flow of $273.5 million, improving net leverage to 2.6 times. The company also repurchased $56 million in shares.
- For full year 2026, Ingevity expects net sales between $1.1 billion and $1.2 billion, adjusted EBITDA between $380 million and $400 million, and adjusted EPS between $4.80 and $5.20.
2 days ago
Ingevity Completes Sale of CTO Refinery Assets and Industrial Specialties Product Line
NGVT
M&A
- Ingevity Corporation announced the successful completion of the sale of its North Charleston Crude Tall Oil (CTO) refinery assets and the majority of its Performance Chemicals Industrial Specialties product line to Mainstream Pine Products, LLC.
- The transaction was completed on January 1, 2026, for an all-cash consideration of $110 million at closing, with potential contingent consideration ranging from $0 to $19 million.
- This sale is a key step in Ingevity's strategy to simplify and streamline its business, focusing on higher-margin specialty applications in activated carbon and pavement technologies, while retaining its Pavement Technologies business and other lignin-based dispersant products.
Jan 5, 2026, 11:39 AM
Ingevity Announces Business Simplification and New Strategic Focus with 2027E Financial Outlook
NGVT
Guidance Update
M&A
New Projects/Investments
- Ingevity is undergoing a business simplification by exiting Industrial Specialties and initiating sales processes for Advanced Polymer Technologies and Road Markings.
- The "New Ingevity" will focus on two core businesses: Performance Materials and Pavement Technologies, aiming for superior and consistent profitability.
- The company projects 2027E Revenue of $940-980 million, EBITDA of $350-370 million, and an EBITDA Margin of 36-39% for the New Ingevity.
- Ingevity expects to generate $200M+ of free cash flow per year in 2026/2027 and targets a Net Debt to Adjusted EBITDA leverage of 2-2.5x.
- The strategy includes leveraging strong cash flow and divestiture proceeds to invest in organic growth, reduce debt, and return significant capital to shareholders.
Dec 8, 2025, 2:00 PM
Ingevity Announces Strategic Portfolio Update and Financial Outlook
NGVT
M&A
Guidance Update
Share Buyback
CFO Change
- Ingevity announced a strategic portfolio transformation, initiating sales processes for its Advanced Polymer Technologies and Road Markings businesses, and is on track to close the sale of Industrial Specialties by early 2026. The company will focus on two core segments: Performance Materials and Pavement Technologies.
- The "new Ingevity" is projected to achieve pro forma revenue of around $900 million with EBITDA margins of approximately 37%. The company anticipates generating nearly $1 billion in deployable cash over the next two years, targeting annual revenue and EBITDA growth over 3%, and annual EPS growth above 10%.
- Capital allocation priorities include fueling organic growth, reducing debt to a target leverage of 2-2.5 times, and returning capital to shareholders, with plans to utilize the remaining $300 million share repurchase authorization over the next two years. M&A is not a priority for the next two years.
- Mary Hall will depart as CFO in May 2026, and Phil Platt has been appointed as the incoming CFO.
Dec 8, 2025, 2:00 PM
Ingevity announces strategic portfolio update and CFO transition
NGVT
CFO Change
M&A
Share Buyback
- Mary Hall will depart as CFO in May 2026, and Phil Platt has been appointed as the incoming CFO.
- Ingevity is selling its Industrial Specialties business (expected to close by early 2026) and has initiated sales processes for its Advanced Polymer Technologies and Road Markings businesses to focus on core competencies.
- The "New Ingevity" will be built around two segments, Performance Materials (a $600 million business with 50%+ EBITDA margins) and Pavement Technologies (a $300 million business with mid-to-high teens margins), aiming for a pro forma revenue of around $900 million and 37% EBITDA margins.
- The company expects to generate nearly $1 billion in deployable cash over the next two years, prioritizing organic growth, debt reduction, and a minimum of $300 million in share repurchases, with the majority of remaining cash going towards debt paydown. This strategy is expected to drive double-digit EPS growth over the next few years.
Dec 8, 2025, 2:00 PM
Quarterly earnings call transcripts for Ingevity.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more